QSAM BioSciences (QB) Stock Price

0.0009 (0.51%)
Volume 1,333
Bid Price 0.1762
Ask Price 0.195
News -
Day High 0.18842


52 Week Range


Day Low 0.176
Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
QSAM BioSciences Inc (QB) QSAM OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0009 0.51% 0.1762 12:12:54
Open Price Low Price High Price Close Price Prev Close
0.176 0.176 0.18842 0.1753
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
5 1,333 $ 0.177916 $ 237 - 0.1469 - 1.09
Last Trade Time Type Quantity Stock Price Currency
12:12:54 100 $ 0.1762 USD


Draw Mode:

QSAM BioSciences Inc (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 4.87M 27.65M 5.50M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
826.00 $ - - - -

more financials information »

QSAM BioSciences (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical QSAM Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.17530.188420.17530.17535000.00090.51%
1 Month0.269750.269750.15010.180368428,016-0.09355-34.68%
3 Months0.36990.36990.14690.249095522,396-0.1937-52.37%
6 Months0.43350.510.14690.314663421,744-0.2573-59.35%
1 Year0.611.090.14690.541260442,350-0.4338-71.11%
3 Years0.202.100.14690.538570340,887-0.0238-11.9%
5 Years0.202.100.14690.538570340,887-0.0238-11.9%

QSAM BioSciences (QB) Description

QSAM Bioscience, Inc. (f/k/a Q2Earth. Inc.) holds the worldwide license for CycloSam (Samaium-153 DOTMP), a clinical stage novel radiopharmaceutical meant to treat different types of bone cancer and related diseases. This nuclear technology uses low specific activity Samarium-153 (resulting in far less europium) and DOTMP, a chelator which is believed to eliminate off-target migration and targets high bone turn over making it an ideal agent to treat osteosarcoma, bone metastases and to perform bone marrow ablation. Sm-153 DOTMP has been cleared by the FDA under an investigator initiated IND to commence human dosing of cancer patients.

Your Recent History
QSAM BioSc..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.